Enhancing Safety & Advancing QA
Save the date: FRIDAY, 27 & SATURDAY, 28
FEBRUARY, 2026
The 15th installment of QADS returns in 2026, with a new European destination — Rome, Italy. Over two days, attendees will learn best practices and clinical insights from colleagues practicing worldwide, while earning continuing education credits.
Session topics will span:
- Future Directions of Machine and Patient QA
- In-vivo Dosimetry and SRS/SBRT QA
- Safety, QC & Guidelines; Using the Rght Tool for the Job
- Emerging Technologies: Theranostics
- Emerging Technologies: AI and Automation
Registration Now Open
We welcome you to the premier educational event focused exclusively on strategies for continuous improvements in Quality and Patient Safety in Radiation Therapy. See below for pricing:
- Student $249
- Early Bird $349 - Until 15 December
- Standard - $399 - 16 December through 13 February
- Onsite - $599 - After 13 February
See below for sample QADS agenda.
2026 agenda coming fall 2025
8:45
2024 Program Introduction
Greg Robinson, M.Sc., CMD, RTT, Sun Nuclear, a Mirion Medical Company, United States
9:00
Keynote Presentation: ESTRO Initiatives to Improve Safety and Quality Throughout the Patient Treatment Course
Nuria Jornet, Ph.D., Hospital de la Santa Creu i Sant Pau, Spain
9:30
Developing a Voluntary Incident Reporting and Learning System and Defining Radiation Protection in Radiotherapy (ROSEIS)
Mary Coffey, RTT, Trinity College, Ireland
10:00
BREAK
10:30
Cybersecurity Risks: Experience and Lessons from a Hospital Cyberattack
Carla Cases, BSc, Hospital Clínic de Barcelona, Spain
11:00
Before and After: Standardization of Machine QA, with Updates from 4-Year Study on IC PROFILER for Dosimetry Tests
David Barbee, Ph.D., DABR, NYU Langone Health, United States
11:30
Moving Towards Process-based Radiotherapy Quality Assurance Using Statistical Process Control
Vysakh Raveendran, Ph.D., Advanced Center for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Hospital, India
11:40
Panel Discussion
Moderators: Jie Shi, Ph.D., and Michaël Claessens, Ph.D.
12:15
LUNCH
13:15
AAPM Task Group Report 307: Use of EPIDs for Patient-Specific IMRT and VMAT QA
Kyle Padgett, Ph.D., University of Miami Medical School, United States
13:45
IPEM Topical Report Guidance for the Clinical Implementation of Online Treatment Monitoring Solutions for IMRT/ VMAT
Simon Stevens, M.Sci., M.Sc., CSci, CMgr, DiplPEM, MIPEM, MInstP, ARCS, The London Clinic, UK
14:15
Validation and Quality Assurance of EPID Transit Dosimetry Algorithms
Marco Esposito, Ph.D., The Abdus Salam International Centre for Theoretical Physics, Italy
14:45
Assessing the Impact of Adaptations to the Clinical Workflow and Identifying Head and Neck Cancer Patients Needing Adaptive Radiotherapy Using Transit In-Vivo Dosimetry
Evy Bossuyt, M.Sc., Iridium Netwerk, Belgium
15:15
BREAK
15:45
A Method for Monitoring Single Fraction Stereotactic Treatments with the EPID
Paul Doolan, Ph.D., German Oncology Center, Cyprus
16:00
Assessing In-Vivo 2D Image Analysis Sensitivity in Breast Cancer Treatments Using PerFRACTION
Maria do Carmo Lopes, Ph.D., IPO Coimbra, Portugal
16:15
Testing PerFRACTION Transit In-Vivo Dosimetry Ability to Detect Delivery Errors on a Clinical Spine SBRT Case
Fátima María Leo Martínez, M.Sc., Hospital de la Santa Creu i Sant Pau, Spain
16:30
Panel Discussion
Moderators: Jennifer Hamilton, M.E., DABR and Mary Coffey, RTT
18:00
Networking Reception
Scale Bar & Terrace
2026 agenda coming fall 2025
8:00
Al applications and QA of Al in Radiotherapy - Contouring, Pre-T QA and QA of FLASH
Michaël Claessens, Ph.D., Iridium Netwerk, Belgium
8:30
Looking to the Future of AI: How MDs Could Use AI to Write More Personalized Prescriptions/Carepaths
David Lindsay, Ph.D., Oncora Medical, Inc., United States
9:00
A Clinical Evaluation of the Performance of Five Commercial Artificial Intelligence Contouring Systems for Radiotherapy
Efstratios Karagiannis, M.D., Ph.D., KSGR, Switzerland
9:30
BREAK
10:00
Artificial Intelligence and RT Workflows
Pauline Maury, Ph.D., Gustave Roussy, France
10:30
Panel Discussion
Moderators: Greg Robinson, M.Sc., CMD, RTT and Michael Tallhammer, M.Sc., DABR
11:00
Clinical Application of Theranostics and How to Approach Patient QA
Robert Francois Hobbs, Ph.D., Johns Hopkins University, United States
11:30
Moving from CT-Sim to MR-Sim
Teo Stanescu, Ph.D., MCCPM, Princess Margaret Cancer Centre, Canada
12:00
Latest Developments and Novel Clinical Uses for SGRT
Michael Tallhamer, M.Sc., DABR, AdventHealth Parker, United States
12:30
LUNCH
13:15
A Novel Platform for the QA of Synchrony Real-time Tumor Tracking Radiotherapy Systems
Roland Teboh Forbang, M.S., Ph.D., DABR, John Theurer Cancer Center, Hackensack Meridian Health, United States
13:45
Comprehensive QA Program in a MRI-LINAC System Using Sun Nuclear Tools
Matteo Galetto, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Italy
14:15
Panel Discussion
Moderators: Jie Shi, Ph.D. and Nuria Jornet, Ph.D.
14:45
BREAK
15:00
Understanding Solid State Dosimeters and Their Increasing Role in Medical Physics Quality Assurance Measurements
Wesley Culberson, Ph.D., DABR, University of Wisconsin – Madison, United States
15:30
A Hybrid Method for Patient Specific QA for SRS and SBRT Cases Utilizing 3D Secondary Dose Verification as a Screening Tool
Remy Manigold, DMP, DABR, Scripps, United States
16:00
Systematic Evaluation of Spatial Resolution and Gamma Criteria for Quality Assurance with Detector Arrays in Stereotactic Radiosurgery
Mark Chofor, Ph.D., Sun Nuclear, a Mirion Medical Company, United States
16:15
Novel Multi-Isocenter Accuracy Testing and Patient Specific QA for Gyroscopic Radiosurgery System
Carlos Rodrigues, M.Sc., Mercurius Health, Portugal
16:45
Individual Target Dose Evaluation for SIMT Using SRS MapCHECK and Independent Monte Carlo
Justus Adamson, Ph.D., DABR, Duke University, United States
Starts Here™
Sun Nuclear does a great job selecting interesting and well-balanced topics for QADS.
ENDORSED BY AAPM
AAPM does not endorse the product in question; rather, they endorse the program's educational component.
Need support on getting approval to attend? Use our justification letter to get started.
*Student pricing subject to student identification proof. Alumni pricing subject to confirmation of prior QADS attendance.